SCHEMBL2396925

SCHEMBL2396925

C#CC(N)C1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2394562 0.97 EPHX1 (0.39)
SCHEMBL6880531 0.97 EPHX1 (0.39)
SCHEMBL4624168 0.74 NCF1 (0.37)
SCHEMBL15045495 0.74
SCHEMBL4042923 0.72
SCHEMBL7140449 0.72
SCHEMBL15045503 0.72
SCHEMBL7139260 0.70 EPHX1 (0.34)
SCHEMBL4040242 0.70 EPHX1 (0.41)
SCHEMBL5646565 0.70 EPHX1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9245290-B2 Caspase inhibitors and uses thereof BUCK INSTITUTE FOR RESEARCH ON AGING (US) 2016-01-26 US disclosed
US-20140011847-A1 CASPASE INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-01-09 US disclosed
US-8518942-B2 Caspase inhibitors and uses thereof BUCK INSTITUTE FOR RESEARCH ON AGING (US) 2013-08-27 US disclosed
US-20110230527-A1 CASPASE INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2011-09-22 US disclosed